TrialChest2020

Low Prognostic Value of Novel Nocturnal Metrics in Patients With OSA and High Cardiovascular Event Risk: Post Hoc Analyses of the SAVE Study.

Dominik Linz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.